Items list
The BioFlo® Midline Catheter is the first—and only—midline catheter with Endexo® Technology, providing a catheter material more resistant to in-vitro thrombus accumulation compared to commonly used catheters (based on platelet count). Endexo® Technology is present throughout the catheter shaft, including the intraluminal, extraluminal, and cut surface, and remains for the life of the catheter.
The BioFlo® Midline Catheter provides short-term access (<30 days) to the peripheral venous system and is intended for selected intravenous therapies and blood sampling. It is a 20 cm trimmable catheter and, in acute in-vitro testing, demonstrated 94% less thrombus accumulation compared to competitors (based on platelet count).
For Full Details Visit: spectrumvascular.com/sv-midlines
The BioFlo® Midline Catheter provides short-term access (<30 days) to the peripheral venous system and is intended for selected intravenous therapies and blood sampling. It is a 20 cm trimmable catheter and, in acute in-vitro testing, demonstrated 94% less thrombus accumulation compared to competitors (based on platelet count).
For Full Details Visit: spectrumvascular.com/sv-midlines
